|
US6465427B1
(en)
|
1996-07-12 |
2002-10-15 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US7122623B2
(en)
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
US6610821B1
(en)
*
|
1996-07-12 |
2003-08-26 |
Mcgill University |
Compounds and methods for modulating endothelial cell adhesion
|
|
US20040006011A1
(en)
*
|
1996-07-12 |
2004-01-08 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US6207639B1
(en)
*
|
1996-07-12 |
2001-03-27 |
Mcgill University |
Compounds and methods for modulating neurite outgrowth
|
|
US6169071B1
(en)
*
|
1996-07-12 |
2001-01-02 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US6417325B1
(en)
*
|
1996-07-12 |
2002-07-09 |
Mcgill University |
Compounds and methods for cancer therapy
|
|
US20020168761A1
(en)
|
2000-01-24 |
2002-11-14 |
Gour Barbara J. |
Peptidomimetic modulators of cell adhesion
|
|
US6562786B1
(en)
|
1996-07-12 |
2003-05-13 |
Mcgill University |
Compounds and methods for modulating apoptosis
|
|
AU722985B2
(en)
|
1996-07-12 |
2000-08-17 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US6333307B1
(en)
*
|
1996-07-12 |
2001-12-25 |
Mcgill University |
Compounds and method for modulating neurite outgrowth
|
|
US6346512B1
(en)
*
|
1996-07-12 |
2002-02-12 |
Mcgill University |
Compounds and methods for modulating cell adhesion
|
|
US6551994B1
(en)
|
1997-04-10 |
2003-04-22 |
Mcgill University |
Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
|
|
US7481999B2
(en)
|
1998-05-05 |
2009-01-27 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin-mediated function
|
|
EP1075494A2
(en)
|
1998-05-05 |
2001-02-14 |
Adherex Technologies, Inc. |
Compounds and methods for modulating nonclassical cadherin-mediated functions
|
|
US20050203025A1
(en)
*
|
1998-05-05 |
2005-09-15 |
Adherex Technologies, Inc. |
Compounds and methods for modulating nonclassical cadherin-mediated functions
|
|
US6472367B1
(en)
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
|
US6638911B1
(en)
*
|
1998-05-05 |
2003-10-28 |
Adherex Technologies Inc. |
Compounds and methods for modulating desmosomal cadherin-mediated functions
|
|
US6680175B2
(en)
|
1998-05-05 |
2004-01-20 |
Adherex Technologies, Inc. |
Methods for diagnosing and evaluating cancer
|
|
EP1091762A1
(en)
|
1998-07-02 |
2001-04-18 |
Genzyme Corporation |
Transgene expression in polarized cells
|
|
US6277824B1
(en)
|
1998-07-10 |
2001-08-21 |
Adherex Technologies |
Compounds and methods for modulating adhesion molecule function
|
|
AU4417000A
(en)
*
|
1999-04-15 |
2000-11-02 |
Glaxo Group Limited |
Novel pharmaceutical composition suitable for gene therapy
|
|
US20040254099A1
(en)
*
|
1999-04-21 |
2004-12-16 |
Adherex Technologies, Inc. |
Compounds and methods for modulating beta-catenin mediated gene expression
|
|
US6303576B1
(en)
*
|
1999-04-21 |
2001-10-16 |
Adherex Technologies Inc. |
Compounds and methods for modulating β-catenin mediated gene expression
|
|
US6391855B1
(en)
*
|
1999-06-02 |
2002-05-21 |
Adherex Technologies, Inc. |
Compounds and methods for modulating junctional adhesion molecule-mediated functions
|
|
US6787136B1
(en)
|
1999-09-03 |
2004-09-07 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
|
|
AU2002226075A1
(en)
*
|
2000-10-23 |
2002-05-06 |
University Of Kansas |
Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion
|
|
US6815426B2
(en)
*
|
2001-02-16 |
2004-11-09 |
E. I. Du Pont De Nemours And Company |
Angiogenesis-inhibitory tripeptides, compositions and their methods of use
|
|
US20020192206A1
(en)
*
|
2001-05-05 |
2002-12-19 |
Kozarov Emil V. |
Methods and compositions for angioproliferative disorder treatment
|
|
US20030105025A1
(en)
*
|
2001-10-31 |
2003-06-05 |
Fortuna Haviv |
Tri-and tetrapeptides having antiangiogenic activity
|
|
US7175990B2
(en)
*
|
2002-02-26 |
2007-02-13 |
The Regents Of The University Of California |
Method of determining endometrial receptivity
|
|
CA2504768A1
(en)
*
|
2002-11-14 |
2004-05-27 |
Adherex Technologies, Inc. |
Compounds and methods for modulating functions of classical cadherins
|
|
AU2003298475A1
(en)
*
|
2002-11-14 |
2004-06-18 |
Adherex Technologies, Inc. |
Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
|
|
US7196061B2
(en)
|
2003-09-10 |
2007-03-27 |
Wyeth |
Compounds that modulate neuronal growth and their uses
|
|
WO2005039506A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Exelixis, Inc. |
P70s6 kinase modulators and method of use
|
|
US20080139560A1
(en)
*
|
2004-03-08 |
2008-06-12 |
Scion Pharmaceuticals, Inc. |
Ion Channel Modulators
|
|
US7169756B2
(en)
*
|
2004-04-16 |
2007-01-30 |
Mcmaster University |
Streptogramin antibiotics
|
|
CA2763671A1
(en)
*
|
2005-04-26 |
2006-11-02 |
Pfizer Inc. |
P-cadherin antibodies
|
|
CA2623565A1
(en)
|
2005-09-28 |
2007-04-05 |
Biovascular, Inc. |
Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
|
|
US20110034396A1
(en)
*
|
2005-09-28 |
2011-02-10 |
Biovascular, Inc. |
Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
|
|
US20110123535A1
(en)
*
|
2006-05-15 |
2011-05-26 |
Biogen Idec Ma Inc. |
Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival
|
|
WO2008039525A2
(en)
*
|
2006-09-27 |
2008-04-03 |
Adherex Technologies, Inc. |
Cadherin antagonists in combination with anticancer agents for use in cancer treatment
|
|
EP2997973A1
(en)
|
2006-11-15 |
2016-03-23 |
Dana-Farber Cancer Institute, Inc. |
Stabalized maml peptides and uses thereof
|
|
US20090291967A1
(en)
*
|
2008-03-05 |
2009-11-26 |
Adherex Technologies, Inc. |
Small molecule modulators of cell adhesion
|
|
US9599603B2
(en)
*
|
2008-07-16 |
2017-03-21 |
Case Western Reserve University |
Methods and compositions for modulating adhesion and migration of cadherin expressing cells
|
|
US9175047B2
(en)
|
2009-01-14 |
2015-11-03 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US8680150B2
(en)
|
2009-05-28 |
2014-03-25 |
Ligand Pharmaceuticals, Inc. |
Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
|
|
CN102712675A
(zh)
*
|
2009-09-22 |
2012-10-03 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
US8877188B2
(en)
|
2010-05-04 |
2014-11-04 |
The Brigham And Women's Hospital, Inc. |
Detection and treatment of non-dermal fibrosis
|
|
FR2980741B1
(fr)
|
2011-09-30 |
2014-03-14 |
Saint Gobain |
Procede d'assemblage par collage d'un vitrage sur un support avec interposition d'une cale d'ecartement, vitrage muni d'une cale d'ecartement, cale, cordon profile et ensemble de cales.
|
|
US8633158B1
(en)
|
2012-10-02 |
2014-01-21 |
Tarix Pharmaceuticals Ltd. |
Angiotensin in treating brain conditions
|
|
RU2015147241A
(ru)
|
2013-05-24 |
2017-06-29 |
Терикс Фармасьютикалз Лтд. |
Пептиды ангиотензина при лечении синдрома марфана и связанных с ним нарушений
|
|
KR20160065969A
(ko)
|
2013-10-11 |
2016-06-09 |
타릭스 파마슈티컬스 엘티디. |
신규 펩티드 조성물
|
|
US9133241B2
(en)
|
2013-10-11 |
2015-09-15 |
Tarix Pharmaceuticals Ltd. |
Peptide compositions
|
|
EP3074417A4
(en)
|
2013-11-25 |
2017-05-03 |
Unm.Stc |
Cxcr antagonistic peptides and uses thereof
|
|
US9333233B2
(en)
|
2014-02-25 |
2016-05-10 |
Tarix Pharmaceuticals Ltd. |
Methods and compositions for the delayed treatment of stroke
|
|
WO2016001810A1
(en)
|
2014-07-01 |
2016-01-07 |
Pfizer Inc. |
Bispecific heterodimeric diabodies and uses thereof
|
|
US11097005B2
(en)
|
2014-12-15 |
2021-08-24 |
The Brigham And Women's Hospital, Inc. |
Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity
|
|
GB2538947A
(en)
*
|
2014-12-19 |
2016-12-07 |
Neuro-Bio Ltd |
Cancer
|
|
WO2016097753A1
(en)
*
|
2014-12-19 |
2016-06-23 |
Neuro-Bio Ltd |
Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasis
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2017066552A1
(en)
|
2015-10-14 |
2017-04-20 |
Tarix Pharmaceuticals Ltd. |
Methods and compositions for the treatment of epidermolysis bullosa
|
|
KR102167755B1
(ko)
*
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
|
JP2022544640A
(ja)
*
|
2019-06-21 |
2022-10-20 |
ユニバーシティ オブ カンザス |
脳疾患の治療に有用な組成物および方法
|
|
WO2021183863A1
(en)
|
2020-03-13 |
2021-09-16 |
Constant Therapeutics Llc |
Methods and compositions for treatment of coronavirus infection
|
|
KR102911194B1
(ko)
*
|
2020-11-05 |
2026-01-13 |
한국생명공학연구원 |
항염 및 조직 재생작용을 갖는 신규 펩타이드
|
|
CN116535406B
(zh)
*
|
2022-01-25 |
2025-06-24 |
中国科学院大连化学物理研究所 |
一种多萜衍生物的对映选择性合成方法及多萜衍生物
|
|
CN116535281B
(zh)
*
|
2022-01-25 |
2025-06-24 |
中国科学院大连化学物理研究所 |
一种手性环状单萜衍生物及其合成方法
|
|
WO2025122594A1
(en)
|
2023-12-04 |
2025-06-12 |
Constant Therapeutics, Llc |
Improved methods and compositions for the treatment of pemphigus or pemphigoid disease
|
|
WO2025137668A1
(en)
|
2023-12-21 |
2025-06-26 |
Constant Therapeutics, Llc |
Methods and compositions for the treatment of optic neuropathy
|